The committee for SCREEN will receive and answer all new queries for collaboration and review them for the following criteria:
- That the research is relevant to the strategy at SDCC with an emphasis on world-class patient-centered diabetes care.
- That the available resources and patient population match the research objectives and enrollment criteria.
- That there is synergy between clinical research at SDCC.
It is no longer possible to initiate external collaborations with individual researchers outside of SCREEN. All clinical trials initiated and conducted at SDCC need to go through the SCREEN process.
If your participants need to sign an informed consent, then it’s likely that your project needs to be approved by SCREEN. If in doubt, contact Michelle Ellefson, Head of Research & Innovation at SDCC.
Applicants will be notified within 7 business days of the SCREEN SC decision.
SCREEN Steering Committee Members
Birgitte Brock, Head of Research, chairman
Peter Rossing, Head of Complications Research
Anne Mette Rosenfalck, Head of Clinic
Kirsten Nørgaard, Head of Diabetes Technology
Allan Vaag, Head of Type 2 Diabetes Biology
Kristine Færch, Head of Diabetes Prevention Research
Ingrid Willaing, Head of Diabetes Management Research
Morten Hulvej Rod, Head of Health Promotion Research
Evy Connie Ottesen, Head of CoreLab
Michelle Ellefson, Head of Research and Innovation
SCREEN 2020 Deadlines and SC Meetings
Steering Committee Meetings | Deadline for material to be sent |
| January | 21 December 2019 |
| February | 6 February |
| March | 9 March |
| April | 6 April |
| May | 7 May |
| June | 11 June |
| August | 6 August |
| September | 7 September |
| October | 1 October |
| November | 3 November |
| December | 4 December |
A more detailed description of SCREEN can be found in the white paper below: